跳至主要内容
临床试验/NCT00431418
NCT00431418已完成3 期

The Effect of Sildenafil in Preterm Infants With Evolving Chronic Lung Disease (SPICE Trial): a Pilot Study

Mercy Hospital for Women, Australia1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2007年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Length of ventilation

研究概览

简要总结

The purpose of this pilot study is to investigate in a randomised double-blind trial whether treatment with Sildenafil reduces duration of ventilatory support in preterm infants born at 28 weeks of gestation or less.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
— 至 7 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Newborn babies born <28 weeks of gestation who still need ventilatory support via endotracheal tube or have been re-ventilated at day 7 of life.

排除标准

  • Congenital heart defects
  • Suspected inborn error of metabolism
  • Inhaled Nitric Oxide treatment during assessment

研究组 & 干预措施

1

Active Comparator

Sildenafil oral solution.

干预措施: Sildenafil (Drug)

2

Placebo Comparator

Placebo oral solution.

干预措施: Placebo (Drug)

结局指标

主要结局

Length of ventilation

时间窗: 12 months after completion of study

次要结局

  • Bronchopulmonary Dysplasia (BPD)(12 months after completion of study)

研究者

发起方
Mercy Hospital for Women, Australia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Kai Konig

Consultant Neonatologist

Mercy Hospital for Women, Australia

研究点 (1)

Loading locations...

相似试验